HopeStage
Back to all studies
RecruitingNCT06917950

Roxadustat and bone and mental health during dialysis

About this titleRead the official source — NCT06917950
Medication studyAges 18+EgyptAnxiety
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Al MansurahSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 15, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
46
Sponsor
Mansoura University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Egypt
Age range
Over 18 Years
Official registry ID
NCT06917950
Official title
Show the full official title

Effect of Roxadustat on Bone and Neuropsychiatric Aspects in End Stage Kidney Disease Patients on Hemodialysis

Recruitment & locations

Currently recruiting

Al Mansurah

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mansoura University, a university.

Does this study involve medication?

Yes. The study involves medication, including Roxadustat and Conventional Anemia Management.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies